L. Colleter

Délégation Paris 7

Papers

1

Total Citations

29

H-Index

1

About

Dr. L. Colleter is a leading urologic oncologist whose research focuses on optimizing treatment strategies for renal cell carcinoma, particularly through minimally invasive techniques. Their major contribution lies in directly comparing the oncological efficacy of robot-assisted partial nephrectomy (RAPN) and percutaneous cryoablation (PCA) for T1 renal tumors. In their highly cited 2018 study, Dr. Colleter conducted a rigorous retrospective analysis, matching patients on radiological stage and renal score to provide a balanced comparison of peri-operative and local control outcomes. This work, with 29 citations, is pivotal in guiding clinical decision-making, offering crucial data on the trade-offs between surgical resection and ablation. By clarifying the oncological safety and effectiveness of these approaches, Dr. Colleter has helped shape modern, nephron-sparing paradigms for kidney cancer management, directly impacting how surgeons and interventional radiologists select treatments for their patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
29
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Peri‐operative and local control outcomes of robot‐assisted partial nephrectomy vs percutaneous cryoablation for renal masses: comparison after matching on radiological stage and renal score
29 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Délégation Paris 7

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago